key: cord-0830031-ge30i26y authors: Seifert, Stephanie N.; Schulz, Jonathan E.; Ricklefs, Stacy; Letko, Michael; Yabba, Elangeni; Hijazeen, Zaidoun S.; Holloway, Peter; Al-Omari, Bilal; Talafha, Hani A.; Tibbo, Markos; Adney, Danielle R.; Guitian, Javier; Amarin, Nadim; Richt, Juergen A.; McDowell, Chester; Steel, John; Abu-Basha, Ehab A.; Al-Majali, Ahmad M.; van Doremalen, Neeltje; Munster, Vincent J. title: Limited Genetic Diversity Detected in Middle East Respiratory Syndrome-Related Coronavirus Variants Circulating in Dromedary Camels in Jordan date: 2021-03-31 journal: Viruses DOI: 10.3390/v13040592 sha: f99944fdf8b9153268b0d81eb5051cb6eec94d5c doc_id: 830031 cord_uid: ge30i26y Middle East respiratory syndrome-related coronavirus (MERS-CoV) is a persistent zoonotic pathogen with frequent spillover from dromedary camels to humans in the Arabian Peninsula, resulting in limited outbreaks of MERS with a high case-fatality rate. Full genome sequence data from camel-derived MERS-CoV variants show diverse lineages circulating in domestic camels with frequent recombination. More than 90% of the available full MERS-CoV genome sequences derived from camels are from just two countries, the Kingdom of Saudi Arabia (KSA) and United Arab Emirates (UAE). In this study, we employ a novel method to amplify and sequence the partial MERS-CoV genome with high sensitivity from nasal swabs of infected camels. We recovered more than 99% of the MERS-CoV genome from field-collected samples with greater than 500 TCID(50) equivalent per nasal swab from camel herds sampled in Jordan in May 2016. Our subsequent analyses of 14 camel-derived MERS-CoV genomes show a striking lack of genetic diversity circulating in Jordan camels relative to MERS-CoV genome sequences derived from large camel markets in KSA and UAE. The low genetic diversity detected in Jordan camels during our study is consistent with a lack of endemic circulation in these camel herds and reflective of data from MERS outbreaks in humans dominated by nosocomial transmission following a single introduction as reported during the 2015 MERS outbreak in South Korea. Our data suggest transmission of MERS-CoV among two camel herds in Jordan in 2016 following a single introduction event. Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic betacoronavirus with frequent spillover from dromedary camels into humans, primarily in the Eastern Mediterranean Region. Human-to-human transmission is limited with the exception of hospital settings where nosocomial transmission leads to outbreaks of MERS characterized by severe respiratory distress and a case-fatality rate of over 30% in confirmed cases. The majority of confirmed MERS cases have occurred in the Kingdom of Saudi Arabia (KSA) [1] where large camel markets have been shown to support endemic transmission of diverse lineages of MERS-CoV among camels, including individuals infected with multiple MERS-CoV variants simultaneously [2] . Analysis of full MERS-CoV genome sequences sampled from large camel markets in the United Arab Emirates (UAE) revealed a similar pattern in co-housed camels shown to be infected with MERS-CoV from diverse genetic lineages [3] . Phylodynamic analyses supports that the evolution of MERS-CoV, including extensive recombination, occurs primarily in camels rather than in humans [4] , suggesting that maintenance of MERS-CoV populations in camels is an important component of generating viral diversity. Availability of additional camel-derived MERS-CoV genomes will help to reveal further information about the diversity and epidemiology of MERS-CoV in its reservoir, the dromedary camel. In this study, we describe a long-range polymerase chain reaction (LRPCR) assay to amplify the MERS-CoV genome from field-collected samples for next generation sequencing (NGS). We demonstrate the utility and sensitivity of this assay by sequencing the genome of MERS-CoV from nasal swabs collected from infected camels in Jordan in May 2016 for which partial spike S2 sequences had been recovered for 16 of 28 camel swabs that had tested positive for MERS-CoV by RT-PCR [5] . We then analyze the genomic sequences from these camels to better understand the population dynamics of MERS-CoV in Jordan where there have been sporadic human MERS outbreaks since 2012 [6, 7] ; however, as of yet, no camel-derived full-length MERS-CoV genome sequences have been published from Jordan. Nasal swabs were collected from camels as described by van Doremalen et al., 2017 [5] . We designed a semi-nested LRPCR assay to produce 5 overlapping amplicons, approximately 6-kilobase pairs (kbp) each in length, spanning approximately 99% of the MERS-CoV genome, including all protein-coding sequences ( Figure 1 ). This method has been applied to sequencing the Ebola virus [8] and henipavirus [9] genomes from complex samples and is compatible with a variety of next generation sequencing platforms, including the field-portable Oxford MinION [8, 9] . Primers were designed targeting conserved regions in order to amplify across all presently described MERS-CoV lineages (Table 1) . Following cDNA synthesis as described in Seifert et al. [8] , 5 µL of template cDNA was added to a reaction mix for each amplicon containing 10 µL of CloneAMP HiFi PCR PreMix (Takara Bio USA, Inc., Mountain View, CA, USA), 0.4 µM of each primer, and H 2 O to 25 µL. The reaction mix was then thermal cycled 35 times at 98 • C for 10 s, 56 • C for 15 s, and 72 • C for 30 s. The process was repeated, with 2 µL of the first-round LRPCR used as template in a second round of LRPCR before visualizing by gel electrophoresis. LRPCR products were purified with AMPure XP beads as previously described in Seifert et al. [8] , pooled at equal molar ratios, prepped for NGS using the TruSeq Nano DNA kit, and paired-end sequencing was completed on the MiSeq platform (Illumina, Inc., San Diego, CA, USA). The BBTools bioinformatics suite (https://sourceforge.net/projects/bbmap/, accessed on 1 February 2021) was used to trim adapter and indexing primer sequences, filter low-quality bases (